Seminar: Clinical & Molecular Oncology

Seminar by invited speaker:

Professor Dr Peter Daniel

Charité Campus Virchow-Klinikum, Humboldt University
& Max-Delbrück-Center for Molecular Medicine, Berlin, Germany

Unexpected findings in the regulation of the Bak pathway in apoptosis

The Centre for Systems Medicine is pleased to announce another speaker of our seminar series. Professor Dr Peter Daniel is Group Leader for Clinical and Molecular Oncology at the Max Delbrück Center for Molecular Medicine, Chairman of the Section Molecular Oncology and Tumor Genetics at Charité Campus Virchow Klinikum and Vice Chairman of the Department of Hematology and Oncology at the University Medical School Charité, Berlin, Germany. Professor Dr Peter Daniel earned his MD and PhD in Internal Medicine in 1987 from the University of Tübingen, Germany. During his postdoctoral training at the German Cancer Research Center, Heidelberg, he investigated the role of the CD95 (APO-1/Fas) death receptor in the regulation of T and B-lymphocyte apoptosis and immune tolerance.
His research is aimed at defining genetic defects in cancer that result in aggressive disease, poor prognosis, and resistance to clinical cancer therapy.

The talk will be held in RCSI on Thursday 07th of June 2012.

 

Comments are closed.